Work

First-in-human, phase I study of TT-00420, a multiple kinase inhibitor, as a single agent in advanced solid tumors.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.3013

Authors: Sarina Anne Piha-Paul, Binghe Xu, Kanwal Pratap Singh Raghav, Funda Meric-Bernstam, Filip Janku, Ecaterina Elena Dumbrava, Siqing Fu, Daniel D. Karp, Jordi Rodon Ahnert, Anthony Paul Conley, Frank Mott, Jaffer A. Ajani, David S. Hong, Ying Fan, Peng Peng, Wendy J. Levin, Brenda Ngo, Qinhua Cindy Ru, Frank Wu, Milind M. Javle

Institutions: The University of Texas MD Anderson Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286293799

Cites:

Cited by: 5

Related to: 10